Stakeholders warn that more EtO facility closures could have a catastrophic result.
Drop the checkbox mentality and embrace accountability and understanding.
Whatever the demands of international regulators, it is public expectations that will ultimately dictate the need for life sciences companies to prepare complete and accurate product data that patients and healthcare providers can scrutinize on demand.
The deal is expected to close in the second half of 2020, but one analyst expects the transaction will raise antitrust issues in the United States.
The future of eye care will sit at the intersection of the digital and physical worlds.
The White House issued a statement on the president’s intent to nominate Hahn, who is currently the chief medical executive at The University of Texas MD Anderson Cancer Center in Houston.
Skin is an ever-changing organ. Its complexity makes it a challenge when designing wearable devices. When you design adhesives and devices that are made to stick to skin, there’s a lot to consider. Start your design with skin in mind. Learn more by reading “Meeting the challenges of skin.”
A technology in development may be able to significantly improve treatment for newborn patients.
The agency continues to monitor the safety of the grafts manufactured by Endologix, while the company defends its safety.
Six medical societies sent a letter to the agency over concern that limiting EtO sterilization will also limit the availability of certain devices to patients.